Role of oxidative stress in geldanamycin-induced cytotoxicity and disruption of Hsp90 signaling complex.
Heat shock protein 90 (Hsp90) is a chaperone protein regulating PC-12 cell survival by binding and stabilizing Akt, Raf-1, and Cdc37. Hsp90 inhibitor geldanamycin (GA) cytotoxicity has been attributed to the disruption of Hsp90 binding, and the contribution of oxidative stress generated by its quinone group has not been studied in this context. Reactive oxygen species (ROS) and cell survival were assessed in PC-12 cells exposed to GA or menadione (MEN), and Akt, Raf-1, and Cdc37 expression and binding to Hsp90 were determined. GA disrupted Hsp90 binding and increased ROS production starting at 1 h, and cell death occurred at 6 h, inhibited by N-acetylcysteine (NAC) without preventing dissociation of proteins. At 24 h, NAC prevented cytotoxicity and Hsp90 complex disruption. However, MnTBAP antioxidant treatment failed to inhibit GA cytotoxicity, suggesting that NAC acts by restoring glutathione. In contrast, 24 h MEN treatment induced cytotoxicity without disrupting Hsp90 binding. GA and MEN decreased Hsp90-binding protein expression, and proteasomal inhibition prevented MEN-, but not GA-induced degradation. In conclusion, whereas MEN cytotoxicity is mediated by ROS and proteasomal degradation, GA-induced cytotoxicity requires ROS but induces Hsp90 complex dissociation and proteasome-independent protein degradation. These differences between MEN- and GA-induced cytotoxicity may allow more specific targeting of cancer cells.
Clark
Christina B
CB
Department of Pharmacology and Toxicology, University of Louisville, Louisville, KY 40292, USA.
Rane
Madhavi J
MJ
El Mehdi
Delphine
D
Miller
Cynthia J
CJ
Sachleben
Leroy R
LR
Gozal
Evelyne
E
D000818:Animals; D016227:Benzoquinones / Q000633:toxicity*; D002470:Cell Survival / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D018841:HSP90 Heat-Shock Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D047029:Lactams, Macrocyclic / Q000633:toxicity*; D018384:Oxidative Stress / Q000187:drug effects*; D016716:PC12 Cells; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism; D051381:Rats; D017382:Reactive Oxygen Species / Q000378:metabolism; D015398:Signal Transduction / Q000187:drug effects*; D014407:Tumor Cells, Cultured; D024483:Vitamin K 3 / Q000494:pharmacology
D016227:Benzoquinones; D018841:HSP90 Heat-Shock Proteins; D047029:Lactams, Macrocyclic; D017382:Reactive Oxygen Species; D024483:Vitamin K 3; D046988:Proteasome Endopeptidase Complex; C001277:geldanamycin
Int J Exp Pathol. 2000 Oct;81(5):323-39
11168679
FEBS Lett. 1996 Feb 26;381(1-2):82-6
8641445
J Biol Chem. 2003 Sep 12;278(37):35231-40
12842893
J Neurosci. 2007 Oct 17;27(42):11214-27
17942716
Autophagy. 2007 Jul-Aug;3(4):295-9
17404494
Genes Cells. 2004 Jun;9(6):533-48
15189447
Crit Rev Clin Lab Sci. 2006;43(2):143-81
16517421
J Mol Med (Berl). 2004 Aug;82(8):488-99
15168026
J Biol Chem. 2002 Oct 18;277(42):39858-66
12176997
FEBS J. 2007 Dec;274(23):6116-27
17970747
J Biol Chem. 2002 Jul 12;277(28):25480-5
11983711
Arch Biochem Biophys. 2000 Dec 1;384(1):59-67
11147836
Clin Cancer Res. 2007 Mar 15;13(6):1769-74
17363531
Biochem Pharmacol. 2008 May 15;75(10):1994-2006
18359006
Cell. 2004 Jan 9;116(1):87-98
14718169
Cell Res. 2006 Nov;16(11):895-901
17088896
J Cell Sci. 2006 Jan 1;119(Pt 1):85-95
16352662
Cancer Res. 2006 Nov 15;66(22):10967-75
17108135
Nature. 2003 Feb 20;421(6925):801-2
12594497
Cell. 1997 Jul 11;90(1):65-75
9230303
Surv Ophthalmol. 2008 Mar-Apr;53(2):150-63
18348880
J Cell Physiol. 2004 Dec;201(3):374-84
15389545
J Biol Chem. 2006 Dec 29;281(52):40485-92
17088248
Cell Res. 2006 Nov;16(11):855-6
17109011
Chem Res Toxicol. 2006 Mar;19(3):376-81
16544941
Exp Physiol. 2007 May;92(3):561-73
17272355
Altern Med Rev. 2003 Aug;8(3):303-18
12946240
Nature. 2003 Sep 25;425(6956):407-10
14508491
Pharmacol Ther. 1998 Aug;79(2):129-68
9749880
Pharmacol Ther. 2004 Mar;101(3):227-57
15031001
J Clin Oncol. 2005 Feb 20;23(6):1078-87
15718306
J Cell Physiol. 2001 Sep;188(3):281-90
11473354
Oncogene. 2007 Nov 8;26(51):7185-93
17525741
J Neurochem. 1999 May;72(5):1939-47
10217271
Leukemia. 2002 Apr;16(4):455-62
11960322
Mol Cell Biol. 1999 Mar;19(3):1661-72
10022854
Cell Stress Chaperones. 1998 Dec;3(4):228-36
9880235
J Biol Chem. 1999 Jun 18;274(25):17525-33
10364185
J Clin Oncol. 2005 Mar 20;23(9):1885-93
15774780
Biochem Biophys Res Commun. 2006 Jun 23;345(1):419-29
16682002
J Biol Chem. 2002 Mar 22;277(12):10346-53
11779851
Biochem J. 2004 Dec 15;384(Pt 3):461-7
15344906
Neuro Oncol. 2005 Jul;7(3):260-78
16053701
Proc Natl Acad Sci U S A. 2000 Sep 26;97(20):10832-7
10995457
Oncogene. 2003 Dec 8;22(56):9041-7
14663482
Biochem Biophys Res Commun. 1997 Oct 29;239(3):655-9
9367823
FEBS J. 2008 May;275(10):2501-11
18400029
Autophagy. 2005 Oct-Dec;1(3):141-5
16874031
Trends Neurosci. 2000 Feb;23(2):59
10652545
J Clin Oncol. 2005 Jun 20;23(18):4152-61
15961763
Endocr Rev. 1997 Jun;18(3):306-60
9183567
Cell. 1997 Apr 18;89(2):239-50
9108479